These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 7046369)

  • 1. A possible role of opioid substances in depression.
    Emrich HM
    Adv Biochem Psychopharmacol; 1982; 32():77-84. PubMed ID: 7046369
    [No Abstract]   [Full Text] [Related]  

  • 2. Behavioral and neuroendocrine effects of opioid receptor agonists in psychopathologic states.
    Judd LL; Risch SC; Segal DS; Janowsky DS; Huey LY
    Psychiatr Clin North Am; 1983 Sep; 6(3):393-402. PubMed ID: 6359090
    [No Abstract]   [Full Text] [Related]  

  • 3. Psychopathology and endorphins.
    Davis GC; Bunney WE
    Adv Biochem Psychopharmacol; 1980; 22():455-63. PubMed ID: 6994443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating opioid peptides in schizophrenia and depression.
    Berger PA; Watson SJ; Akil H; Barchas JD
    Res Publ Assoc Res Nerv Ment Dis; 1986; 64():309-33. PubMed ID: 2941840
    [No Abstract]   [Full Text] [Related]  

  • 5. [Neuropeptide role in the etiology, pathogenesis and clinical aspects of mental diseases].
    Bakharev VD; Tikhomirov SM
    Sov Med; 1984; (6):50-3. PubMed ID: 6147020
    [No Abstract]   [Full Text] [Related]  

  • 6. [Etiologic and therapeutic significance of endorphins in endogenous psychoses].
    Naber D
    Nervenarzt; 1983 Nov; 54(11):573-7. PubMed ID: 6318141
    [No Abstract]   [Full Text] [Related]  

  • 7. Naloxone and naltrexone in mental illness and tardive dyskinesia.
    Volavka J; Anderson B; Koz G
    Ann N Y Acad Sci; 1982; 398():97-102. PubMed ID: 6760771
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacological challenges to the endogenous opioid system in affective illness.
    Cohen MR; Pickar D
    J Clin Psychopharmacol; 1981 Jul; 1(4):223-31. PubMed ID: 7028803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vulnerability to fluoxetine-induced indifference syndrome among opiate addicts: a case report.
    Bertschy G; Baumann P
    Biol Psychiatry; 1995 Sep; 38(6):404-6. PubMed ID: 8547460
    [No Abstract]   [Full Text] [Related]  

  • 10. Possible role of the endogenous opioid system in the placebo response in depression.
    Lichtigfeld FJ; Gillman MA
    Int J Neuropsychopharmacol; 2002 Mar; 5(1):107-8. PubMed ID: 12057036
    [No Abstract]   [Full Text] [Related]  

  • 11. Synaptic plasticity and mood disorders.
    Duman RS
    Mol Psychiatry; 2002; 7 Suppl 1():S29-34. PubMed ID: 11986993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mood disorders in daily practice; the North American consensus statement on the undertreatment of depression].
    Lamberts H; Okkes IM
    Ned Tijdschr Geneeskd; 1997 Aug; 141(34):1643-6. PubMed ID: 9543774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of omega-3 fatty acids in mood disorders.
    Stahl LA; Begg DP; Weisinger RS; Sinclair AJ
    Curr Opin Investig Drugs; 2008 Jan; 9(1):57-64. PubMed ID: 18183532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between premenstrual dysphoric disorder and other mood disorders.
    Yonkers KA
    J Clin Psychiatry; 1997; 58 Suppl 15():19-25. PubMed ID: 9427873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cognitive deficits in depression].
    Kalska H; Kähkönen S
    Duodecim; 2004; 120(14):1738-44. PubMed ID: 15497307
    [No Abstract]   [Full Text] [Related]  

  • 16. Mood and cognitive side effects of interferon-alpha therapy.
    Valentine AD; Meyers CA; Kling MA; Richelson E; Hauser P
    Semin Oncol; 1998 Feb; 25(1 Suppl 1):39-47. PubMed ID: 9482539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New perspectives in the treatment of shock. Use of naloxone].
    González-Esparza L
    Rev Med Univ Navarra; 1982 Mar; 26(1):55-8. PubMed ID: 7111954
    [No Abstract]   [Full Text] [Related]  

  • 18. Endorphins and mood changes in long-distance running.
    Markoff RA; Ryan P; Young T
    Med Sci Sports Exerc; 1982; 14(1):11-5. PubMed ID: 7070250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical studies: the missing antidepressants].
    Faludi G
    Neuropsychopharmacol Hung; 2005 Sep; 7(3):103-4. PubMed ID: 16493873
    [No Abstract]   [Full Text] [Related]  

  • 20. Approaches to neuropeptide and, in particular, endorphin measurements.
    Terenius L
    Adv Biochem Psychopharmacol; 1984; 39():35-43. PubMed ID: 6205562
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.